can semaglutide cause kidney issues FLOW clinical Trial (funded by Novo Nordisk): showed 24% reduction in the risk of disease-related events in people with type 2 diabetes and chronic kidney disease compared to placebo. Investigators RACGP - Study links Ozempic
Description
Most adults do better when they focus on meal structure, protein, hydration, and fewer highly processed trigger foods rather than looking for a perfect or extreme diet
A comprehensive evaluation by a healthcare provider is crucial to weigh the potential benefits of these medications against the risks and ensure patient safety
N Engl J Med (2022) 387(5):43343
Safety considerations align with established GLP-1 agonist protocols, with gastrointestinal effects being the most commonly reported adverse events
10.1001/jamainternmed.2022.0338 JAMA Intern Med
Tirzepatide is a once-weekly injectable medication that works by targeting two gut hormones GLP-1 and GIP that control hunger and blood sugar
